Pharyngitis in low-resources settings: A pragmatic clinical approach to reduce unnecessary antibiotic use

Pediatrics

Volumn 118, Issue 6, 2006, Pages

  Smeesters, Pierre Robert ^a,b   Campos Jr , Dioclécio ^a   Van Melderen, Laurence ^c   De Aguiar, Eurico ^e   Vanderpas, Jean ^d   Vergison, Anne ^b,d  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^e Hospital Regional da Asa Sul   (Brazil)

Author keywords

Antibiotic use; Developing countries; Pharyngitis; Practice guidelines

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BENZATHINE PENICILLIN; CEFALEXIN; MACROLIDE; ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; NEWBORN; OUTCOME ASSESSMENT; PHARYNGITIS; PRESCRIPTION; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; THROAT CULTURE; CLINICAL TRIAL; DRUG UTILIZATION; MICROBIOLOGY; MULTICENTER STUDY; POVERTY; PRESCHOOL CHILD; PROSPECTIVE STUDY; STANDARD;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; PHARYNGITIS; POVERTY; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS;

EID: 33947125031     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1025     Document Type: Article

References (23)

1. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481-493
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587
3. Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5:568-580
4. Rubin MA, Samore MH. Antimicrobial use and resistance. Curr Infect Dis Rep. 2002;4:491-497
5. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105-110
6. Sirinavin S, Dowell SF. Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives. Semin Pediatr Infect Dis. 2004;15:94-98
7. Mol PG, Wieringa JE, Nannanpanday PV, et al. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother. 2005;55:550-557
8. WHO. WHO Global Strategy for Containment of Antibiotic Resistance. Geneva, Switzerland: WHO; 2001:99
9. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002:35:113-125
10. Martin JM, Green M, Barbadora KA, Wald ER. Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics. 2004;114:1212-1219
11. Steinhoff MC, Abd el Khalek MK, Khallaf N, et al. Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children. Lancet. 1997;350:918-921
12. Rimoin AW, Hamza HS, Vince A, et al. Evaluation of the WHO clinical decision rule for streptococcal pharyngitis. Arch Dis Child. 2005;90:1066-1070
13. Attia MW, Zaoutis T, Klein JD, Meier FA. Performance of a predictive model for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med. 2001;155:687-691
14. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158:75-83
15. Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child. 1977;131:514-517
16. Steinhoff MC, Walker CF, Rimoin AW, Hamza HS. A clinical decision rule for management of streptococcal pharyngitis in low-resource settings. Acta Paediatr. 2005;94:1038-1042
17. Amir J, Shechter Y, Eilam N, Varsano I. Group A beta-hemolytic streptococcal pharyngitis in children younger than 5 years. Isr J Med Sci. 1994;30:619-622
18. Levin RM, Grossman M, Jordan C, Ticknor W, Barnett P, Pascoe D. Group A streptococcal infection in children younger than three years of age. Pediatr Infect Dis J. 1988;7:581-587
19. Kaplan EL. Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. Pediatrics. 1996;97(pt 2):945-948
20. Carapetis JR, Currie BJ, Kaplan EL. Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century. Clin Infect Dis. 1999;28:205-210
21. Brazilian Ministry of Health, Sistema Único de Saúde. Ministério da Saúde. Available at: www.datasus.gov.br. Accessed September 22, 2006.
22. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168
23. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005;5:11